Search for: "Astrazeneca" Results 121 - 140 of 1,244
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jul 2011, 1:42 am
Ranbaxy (UK) Ltd. v AstraZeneca AB [2011] EWHC 1831 (Pat) (15 July 2011) raises an interesting point on the interpretation of claims. [read post]
15 Jul 2011, 5:38 am
”Accordingly, Ranbaxy was entitled to its declaration of non infringement and AstraZeneca’s counterclaim for infringement failed. [read post]
27 Oct 2013, 9:55 pm by Patent Docs
Astrazeneca AB et al. v. [read post]
8 Dec 2013, 8:02 pm by Patent Docs
Astrazeneca AB et al. v. [read post]
25 Mar 2012, 9:25 pm by Patent Docs
AstraZeneca AB et al v. [read post]
30 Nov 2006, 9:45 pm
Teva Nexium--AstraZeneca Prilosec--AstraZeneca Rilutek--Impax v. [read post]
25 Apr 2011, 3:16 pm by Phil
In a Notice Letter sent to AstraZeneca and POZEN in March 2011 (Notice Letter), Dr. [read post]
26 May 2012, 8:41 pm by Mark Summerfield
Apotex Pty Ltd v AstraZeneca AB [2011] FCA 1520 (14 December 2011) Apotex Pty Ltd v AstraZeneca AB (No 2) [2012] FCA 142 (28 February 2012) Watson Pharma Pty Ltd v AstraZeneca AB [2012] FCA 200 (9 March 2012) Apotex Pty Ltd v AstraZeneca AB (No 3) [2012] FCA 265 (23 March 2012) AstraZenenca’s cholesterol drug CRESTOR will remain without generic competition in the Australian market for the foreseeable future, following a series of interlocutory decisions… [read post]
4 Aug 2012, 3:29 am by JA Hodnicki
Daniel Sokol Kristina Nordlander & Patrick Harrison (Sidley Austin) address Abuse of Regulatory Procedures in the Pharmaceutical Sector—Developments Since the General Court's Judgment in AstraZeneca. [read post]
4 Aug 2012, 3:29 am by JA Hodnicki
Daniel Sokol Kristina Nordlander & Patrick Harrison (Sidley Austin) address Abuse of Regulatory Procedures in the Pharmaceutical Sector—Developments Since the General Court's Judgment in AstraZeneca. [read post]
29 Apr 2014, 11:52 am by Paul Caron
Mider: If Pfizer is successful in its $98.7 billion takeover of London-based AstraZeneca, there is one big potential loser: the U.S. [read post]
5 Feb 2021, 5:30 am by Ralf Michaels
Indeed, the APA contains an obligation of the buyers to “use Best Reasonable Efforts to assist AstraZeneca in securing the supply” of drug substances and other materials (§ 6.1 APA) as well as an obligation to provide funding to AstraZeneca in order to enable it to procure the necessary materials (§ 7.1 APA). [read post]
13 Apr 2015, 2:51 pm by Tom Lamb
  As regards what that FDA staff document contained and its significance, from an April 10, 2015 Bloomberg news report, "AstraZeneca’s Diabetes Drug May Raise Death Risk, FDA Says":  AstraZeneca Plc’s type 2 diabetes drug Onglyza showed an increased risk of death in an analysis by U.S. regulators of a clinical trial on the heart effects of the treatment. [read post]
20 Sep 2020, 2:48 pm by Sabrina I. Pacifici
AstraZeneca Blueprints – Read the full article on the disclosure…” [read post]
23 Sep 2009, 6:31 am
It took two years before AstraZeneca gave their United States patients and doctors the same warning. [read post]
27 Apr 2010, 12:48 pm by Ronald V. Miller, Jr.
AstraZeneca officially takes a punch in the Seroquel litigation. [read post]
16 Aug 2009, 9:58 pm
Astrazeneca LP et al. v. [read post]